Multicenter Evaluation of Different Anti-Xa Assays and Diluted Russell's Viper Venom Time in Ex Vivo Plasma Samples from Patients Treated with Rivaroxaban or Apixaban. [PDF]
Božič Mijovski M +4 more
europepmc +1 more source
Age and gender disparities in oral anticoagulant use: a nine-year nationwide drug utilization analysis. [PDF]
Omer AAA, Csatordai M, Viola R, Doró P.
europepmc +1 more source
Pulmonary thromboembolism in Glanzmann Thrombasthenia: a case report and systematic literature review. [PDF]
Mohammad Alizade T +3 more
europepmc +1 more source
Recurrent Stroke and Progression of Left Ventricular Thrombus During Apixaban Therapy in a Patient with Severe Ischemic Cardiomyopathy: A Case Report. [PDF]
Babonji A +4 more
europepmc +1 more source
Predictors of Direct Oral Anticoagulant Use in Northern Italy: A Population-Based Study. [PDF]
Ojeda-Fernández L +6 more
europepmc +1 more source
Effectiveness and safety of rivaroxaban vs. apixaban in patients with atrial fibrillation and peripheral artery disease. [PDF]
Dari L +4 more
europepmc +1 more source
Subclinical atrial fibrillation: Implications of recent trials for guideline updates? [PDF]
Pradhan A +3 more
europepmc +1 more source
Prevalence of abnormal uterine bleeding and quality of life after venous thromboembolism by oral anticoagulant use: the GENB-OAC Study. [PDF]
Sarlon-Bartoli G +26 more
europepmc +1 more source
Leukocytoclastic Vasculitis Associated with Coumarin Derivatives: A Case Report. [PDF]
Mahadevappa M +3 more
europepmc +1 more source
Real-World Impact of Amiodarone on Apixaban Population Pharmacokinetics in Hospitalized Patients. [PDF]
Kolowrat S +5 more
europepmc +1 more source

